Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for m root_names_stdName in Standardized Name (approximate match)

Showing 2091 - 2100 of 2364 results

First page
Previous page
Next page
Next page

HUMAN IMMUNOGLOBULIN M

Z033I8A98M

Status:

Possibly Marketed Outside US

Source:

BLA103189

(2009)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d72d56e3-1f27-4ec1-a49d-7c0f8f5bc512

First approved in 2009

Source:

BLA103189

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d72d56e3-1f27-4ec1-a49d-7c0f8f5bc512

Class:

STRUCTURALLY DIVERSE

C13-14 ISOPARAFFIN

E4F12ROE70

Status:

Possibly Marketed Outside US

Source:

M020

(2000)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2686378c-8827-47fb-b3ed-07438bd4e9e2

First approved in 2000

Source:

M020

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2686378c-8827-47fb-b3ed-07438bd4e9e2

Class:

STRUCTURALLY DIVERSE

APRICOT KERNEL OIL PEG-6 ESTERS

DRG3KJZ1TJ

Status:

Possibly Marketed Outside US

Source:

21 CFR 347

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=43ec9a62-83f5-722d-e054-00144ff8d46c

First approved in 1997

Source:

ANDA074164

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8349d8f8-d210-377a-e053-2a91aa0a0233

Class:

STRUCTURALLY DIVERSE

CORN OIL PEG-6 ESTERS

1U4409FY0P

Status:

Possibly Marketed Outside US

Source:

ANDA213317

(1968)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6ca786fb-8f28-d2ac-5d8d-a14c3af6d7a7

First approved in 1968

Source:

ANDA213317

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6ca786fb-8f28-d2ac-5d8d-a14c3af6d7a7

Class:

STRUCTURALLY DIVERSE

Silicified Microcrystalline Cellulose (65 µm)

K2EZE348C4

Status:

Excipient

Source:

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S

Class:

G1 SPECIFIED SUBSTANCE

Tosylamide/Formaldehyde Resin (80% n-Butyl acetate dispersion)

7D4DLW89CB

Status:

Other

Class:

G1 SPECIFIED SUBSTANCE

Rebaudioside M 85%

X3YJ76S94Z

Status:

Other

Class:

G1 SPECIFIED SUBSTANCE

MATRIX-M1 ADJUVANT

YZ7P8Y8ECX

Status:

Other

Class:

G1 SPECIFIED SUBSTANCE

PD-0360324

EF7PK2TQ0U

Status:

Investigational

Source:

NCT01732211: Phase 2 Interventional Terminated Pulmonary Sarcoidosis

(2013)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01732211

Class:

CONCEPT

IMMUNOCYTOKINE NHS-IL12

KF6D9Z1MER

Status:

Investigational

Source:

NCT04708470: Phase 1/Phase 2 Interventional Recruiting Oropharyngeal Cancer

(2021)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04708470

Class:

CONCEPT

Structurally Diverse

HUMAN IMMUNOGLOBULIN M

Structurally Diverse

C13-14 ISOPARAFFIN

Structurally Diverse

APRICOT KERNEL OIL PEG-6 ESTERS

Structurally Diverse

CORN OIL PEG-6 ESTERS

Concept

Silicified Microcrystalline Cellulose (65 µm)

7D4DLW89CB
Not a public record

Concept

Tosylamide/Formaldehyde Resin (80% n-Butyl acetate dispersion)

X3YJ76S94Z
Not a public record

Concept

Rebaudioside M 85%

YZ7P8Y8ECX
Not a public record

Concept

MATRIX-M1 ADJUVANT

Concept

PD-0360324

Concept

IMMUNOCYTOKINE NHS-IL12

Showing 2091 - 2100 of 2364 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1